Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Appl Physiol (1985) ; 104(3): 648-54, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18174393

RESUMO

The main aim of this study was to investigate the bone-sparing effect of hesperidin, one of the main flavonoid present in oranges, in two age groups of ovariectomized female rats, compared with their intact controls. Young (3 mo) and adult (6 mo) female Wistar rats were sham operated (SH) or ovariectomized (OVX) and then pair-fed for 90 days a casein-based diet supplemented or not with 0.5% hesperidin (Hp; n = 10/group). In older rats, Hp intake led to a partial inhibition of OVX-induced bone loss, whereas a complete inhibition was obtained in younger animals. At both ages, while plasma osteocalcin concentrations were unchanged, urinary excretion of deoxypyridinoline was reduced by Hp intake, suggesting that Hp was able to slow down bone resorption. Unexpectedly, in intact young rats, Hp consumption resulted in a significant increase in bone mineral density (BMD). Indeed, 6-mo-old HpSH rats had a similar BMD to 9-mo-old nontreated SH adult rats, suggesting an accelerated bone mass gain in the young rats. In contrast, in intact adult rats, Hp did not further increase BMD but did improve their bone strength. The results of this study show a protective effect of Hp on bone loss in OVX rats of both ages without uterine stimulation and accompanied by a lipid-lowering effect. The unexpected and intriguing findings obtained in intact rats showing improved BMD in young rats and improved femoral load in adult rats merit further investigation. The bone and lipid benefits of hesperidin make it an attractive dietary agent for the management of the health of postmenopausal women.


Assuntos
Conservadores da Densidade Óssea/farmacologia , Densidade Óssea/efeitos dos fármacos , Doenças Ósseas Metabólicas/prevenção & controle , Remodelação Óssea/efeitos dos fármacos , Hesperidina/farmacologia , Hipolipemiantes/farmacologia , Osteoporose/prevenção & controle , Ovariectomia/efeitos adversos , Fatores Etários , Aminoácidos/urina , Animais , Fenômenos Biomecânicos , Composição Corporal , Conservadores da Densidade Óssea/sangue , Conservadores da Densidade Óssea/uso terapêutico , Doenças Ósseas Metabólicas/etiologia , Doenças Ósseas Metabólicas/metabolismo , Doenças Ósseas Metabólicas/fisiopatologia , Reabsorção Óssea/prevenção & controle , Colesterol/sangue , Modelos Animais de Doenças , Feminino , Fêmur/efeitos dos fármacos , Fêmur/fisiopatologia , Hesperidina/sangue , Hesperidina/uso terapêutico , Hipolipemiantes/sangue , Hipolipemiantes/uso terapêutico , Osteocalcina/sangue , Osteoporose/etiologia , Osteoporose/metabolismo , Osteoporose/fisiopatologia , Ratos , Ratos Wistar , Triglicerídeos/sangue , Útero/efeitos dos fármacos , Útero/patologia
2.
Eur J Nutr ; 45(3): 171-7, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16155740

RESUMO

Low intracellular magnesium (Mg) contents may be observed in case of severe Mg insufficient intake or because of genetic regulation. This work was conducted to investigate the influence of intracellular Mg content on erythrocyte Mg(2+) influx and efflux in mice with low nutritionally and genetically (MGL and MGH mice) Mg status. C57BL6 mice were fed for 2 wks a diet containing 1000 mg Mg/kg diet Mg (control group), 100 mg Mg/kg diet (Mg-marginal group) or 30 mg Mg/kg diet (Mg deficient group), while mice with low (MGL) and high (MGH) Mg levels were fed a control diet for 2 wks. The quantification of erythrocyte Mg(2+) influx and efflux was performed using a stable isotope of Mg. Our results showed that erythrocyte Mg(2+) influx and efflux were respectively increased and decreased in nutritional Mg deficiency; while in genetically determined Mg status Mg(2+) fluxes were lower in MGL mice compared to MGH mice. Moreover Mg(2+) efflux was significantly correlated to Mg level in erythrocytes in all the mice studied (p < 0.001). In conclusion, erythrocyte Mg(2+) influx and efflux are modulated by low Mg status, namely decreased Mg(2+) efflux compensate for nutritional Mg deficiency, while the genetic regulation of erythrocyte Mg(2+) content depends on modification of Mg(2+) influx.


Assuntos
Eritrócitos/metabolismo , Deficiência de Magnésio/metabolismo , Magnésio/administração & dosagem , Magnésio/metabolismo , Estado Nutricional , Animais , Animais Geneticamente Modificados , Relação Dose-Resposta a Droga , Feminino , Homeostase/genética , Homeostase/fisiologia , Magnésio/sangue , Camundongos , Camundongos Endogâmicos C57BL
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...